$OYST Oyster Point Pharma, Inc. Insider Trading
Get free email notifications about insider trading in Oyster Point Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Oyster Point Pharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Oyster Point Pharma, Inc. for free.
CIK Number: 0001720725
IRS Number: 811030955
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: OYST
Company Address: 202 CARNEGIE CENTER SUITE 109 PRINCETON 08540
Phone number: (609) 382-9032
Oyster Point Pharma, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2021 | OYST | Oyster Point Pharm ... | WEISNER AIMEE S | Director | Option Exercise | A | 17.74 | 5,199 | 92,230 | 5,199 | |
Jun 09 2021 | OYST | Oyster Point Pharm ... | WEISNER AIMEE S | Director | Grant | A | 0.00 | 3,466 | 0 | 33,191 | 29.7 K to 33.2 K (+11.66 %) |
Jun 09 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Option Exercise | A | 17.74 | 5,199 | 92,230 | 5,199 | |
Jun 09 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Grant | A | 0.00 | 3,466 | 0 | 10,066 | 6.6 K to 10.1 K (+52.52 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 2,018 | 0 | 8,430 | 10.4 K to 8.4 K (-19.31 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 193 | 0 | 7,358 | 7.2 K to 7.4 K (+2.69 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 82,486 | 0 | 0 | 82.5 K to 0 (-100.00 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Buy | J | 0.00 | 82,486 | 0 | 82,486 | 0 to 82.5 K |
May 14 2021 | OYST | Oyster Point Pharm ... | Ozawa Clare | Director | Sell | J | 0.00 | 320,340 | 0 | 1,361,590 | 1.7 M to 1.4 M (-19.05 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 642 | 0 | 1,273 | 631 to 1.3 K (+101.74 %) |
May 14 2021 | OYST | Oyster Point Pharm ... | LINK WILLIAM J PHD | Director | Buy | J | 0.00 | 10,302 | 0 | 20,604 | 10.3 K to 20.6 K (+100.00 %) |
Apr 05 2021 | OYST | Oyster Point Pharm ... | Eliades George Christopher | Director | Grant | A | 0.00 | 1,650 | 0 | 21,585 | 19.9 K to 21.6 K (+8.28 %) |
Apr 05 2021 | OYST | Oyster Point Pharm ... | Eliades George Christopher | Director | Grant | A | 0.00 | 19,935 | 0 | 19,935 | 0 to 19.9 K |
Apr 02 2021 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Option Exercise | M | 1.02 | 10,000 | 10,200 | 494,774 | |
Apr 02 2021 | OYST | Oyster Point Pharm ... | Nau Jeffrey | President and CEO | Buy | M | 1.02 | 10,000 | 10,200 | 50,898 | 40.9 K to 50.9 K (+24.45 %) |